Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial
- PMID: 22031728
- DOI: 10.1001/jama.2011.1591
Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial
Abstract
Context: The effect on mortality of screening for lung cancer with modern chest radiographs is unknown.
Objective: To evaluate the effect on mortality of screening for lung cancer using radiographs in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
Design, setting, and participants: Randomized controlled trial that involved 154,901 participants aged 55 through 74 years, 77,445 of whom were assigned to annual screenings and 77,456 to usual care at 1 of 10 screening centers across the United States between November 1993 and July 2001. The data from a subset of eligible participants for the National Lung Screening Trial (NLST), which compared chest radiograph with spiral computed tomographic (CT) screening, were analyzed.
Intervention: Participants in the intervention group were offered annual posteroanterior view chest radiograph for 4 years. Diagnostic follow-up of positive screening results was determined by participants and their health care practitioners. Participants in the usual care group were offered no interventions and received their usual medical care. All diagnosed cancers, deaths, and causes of death were ascertained through the earlier of 13 years of follow-up or until December 31, 2009.
Main outcome measures: Mortality from lung cancer. Secondary outcomes included lung cancer incidence, complications associated with diagnostic procedures, and all-cause mortality.
Results: Screening adherence was 86.6% at baseline and 79% to 84% at years 1 through 3; the rate of screening use in the usual care group was 11%. Cumulative lung cancer incidence rates through 13 years of follow-up were 20.1 per 10,000 person-years in the intervention group and 19.2 per 10,000 person-years in the usual care group (rate ratio [RR]; 1.05, 95% CI, 0.98-1.12). A total of 1213 lung cancer deaths were observed in the intervention group compared with 1230 in usual care group through 13 years (mortality RR, 0.99; 95% CI, 0.87-1.22). Stage and histology were similar between the 2 groups. The RR of mortality for the subset of participants eligible for the NLST, over the same 6-year follow-up period, was 0.94 (95% CI, 0.81-1.10).
Conclusion: Annual screening with chest radiograph did not reduce lung cancer mortality compared with usual care.
Trial registration: clinicaltrials.gov Identifier: NCT00002540.
Comment in
-
Screening for lung cancer with chest radiographs.JAMA. 2011 Nov 2;306(17):1916-8. doi: 10.1001/jama.2011.1609. Epub 2011 Oct 26. JAMA. 2011. PMID: 22031727 No abstract available.
-
Screening: get it off your chest.Nat Rev Clin Oncol. 2011 Nov 15;8(12):689. doi: 10.1038/nrclinonc.2011.176. Nat Rev Clin Oncol. 2011. PMID: 22083041 No abstract available.
-
Lung cancer screening with chest radiography has no effect on lung cancer incidence or mortality.Evid Based Med. 2012 Oct;17(5):149-50. doi: 10.1136/ebmed-2011-100489. Epub 2012 Feb 18. Evid Based Med. 2012. PMID: 22345033 No abstract available.
-
ACP Journal Club. Screening with chest radiography did not reduce lung cancer mortality in older patients.Ann Intern Med. 2012 Mar 20;156(6):JC3-8. doi: 10.7326/0003-4819-156-6-201203200-02008. Ann Intern Med. 2012. PMID: 22431694 No abstract available.
Similar articles
-
Deep Learning to Assess Long-term Mortality From Chest Radiographs.JAMA Netw Open. 2019 Jul 3;2(7):e197416. doi: 10.1001/jamanetworkopen.2019.7416. JAMA Netw Open. 2019. PMID: 31322692 Free PMC article.
-
Association of Nonadherence to Cancer Screening Examinations With Mortality From Unrelated Causes: A Secondary Analysis of the PLCO Cancer Screening Trial.JAMA Intern Med. 2019 Feb 1;179(2):196-203. doi: 10.1001/jamainternmed.2018.5982. JAMA Intern Med. 2019. PMID: 30592477 Free PMC article. Clinical Trial.
-
Prostate-Specific Antigen-Based Screening for Prostate Cancer: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 May. Report No.: 17-05229-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 May. Report No.: 17-05229-EF-1. PMID: 30085502 Free Books & Documents. Review.
-
Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.JAMA. 2011 Jun 8;305(22):2295-303. doi: 10.1001/jama.2011.766. JAMA. 2011. PMID: 21642681 Clinical Trial.
-
Estimate of lung cancer mortality from low-dose spiral computed tomography screening trials: implications for current mass screening recommendations.J Clin Oncol. 2004 Jun 1;22(11):2202-6. doi: 10.1200/JCO.2004.12.046. J Clin Oncol. 2004. PMID: 15169809 Review.
Cited by
-
Effects of joint screening for prostate, lung, colorectal, and ovarian cancer - results from a controlled trial.Front Oncol. 2024 Apr 29;14:1322044. doi: 10.3389/fonc.2024.1322044. eCollection 2024. Front Oncol. 2024. PMID: 38741776 Free PMC article.
-
Which is a real valuable screening tool for lung cancer and measure thoracic diseases, chest radiography or low-dose computed tomography?: A review on the current status of Japan and other countries.Medicine (Baltimore). 2024 May 10;103(19):e38161. doi: 10.1097/MD.0000000000038161. Medicine (Baltimore). 2024. PMID: 38728453 Free PMC article. Review.
-
Identification and validation of PCDHGA12 and PRRX1 methylation for detecting lung cancer in bronchial washing sample.Oncol Lett. 2024 Apr 3;27(6):246. doi: 10.3892/ol.2024.14379. eCollection 2024 Jun. Oncol Lett. 2024. PMID: 38638845 Free PMC article.
-
Lung cancer screening in Brazil: recommendations from the Brazilian Society of Thoracic Surgery, Brazilian Thoracic Association, and Brazilian College of Radiology and Diagnostic Imaging.J Bras Pneumol. 2024 Mar 22;50(1):e20230233. doi: 10.36416/1806-3756/e20230233. eCollection 2024. J Bras Pneumol. 2024. PMID: 38536982 Free PMC article. Review.
-
Screening for lung cancer with computed tomography: protocol for systematic reviews for the Canadian Task Force on Preventive Health Care.Syst Rev. 2024 Mar 16;13(1):88. doi: 10.1186/s13643-024-02506-3. Syst Rev. 2024. PMID: 38493159 Free PMC article.
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical